Post-exposure diphtheria prevention

Post-exposure diphtheria prevention refers to the clinical management of asymptomatic individuals who have had close, direct contact with a suspected or confirmed case of infection caused by toxigenic *Corynebacterium diphtheriae* (or rarely toxigenic *Corynebacterium ulcerans*) The exposed population encompasses household members, caregivers, and healthcare personnel who have had direct contact with respiratory droplets, oral secretions, or cutaneous exudates of an infected patient This prevent...

Post-exposure diphtheria prevention refers to the clinical management of asymptomatic individuals who have had close, direct contact with a suspected or confirmed case of infection caused by toxigenic *Corynebacterium diphtheriae* (or rarely toxigenic *Corynebacterium ulcerans*)

Post-exposure diphtheria prevention refers to the clinical management of asymptomatic individuals who have had close, direct contact with a suspected or confirmed case of infection caused by toxigenic *Corynebacterium diphtheriae* (or rarely toxigenic *Corynebacterium ulcerans*) The exposed population encompasses household members, caregivers, and healthcare personnel who have had direct contact with respiratory droplets, oral secretions, or cutaneous exudates of an infected patient

The exposed population encompasses household members, caregivers, and healthcare personnel who have had direct contact with respiratory droplets, oral secretions, or cutaneous exudates of an infected patient This preventative strategy involves active clinical surveillance, secondary bacterial culture screening, antimicrobial prophylaxis to eradicate the organism, and updating diphtheria toxoid-containing immunization to boost neutralizing antitoxin antibody levels

Pathophysiologically, the goal is to prevent bacterial colonization, eliminate mucosal carriage, and halt the production of the diphtheria exotoxin, an agent responsible for localized tissue necrosis, pseudomembrane formation across the respiratory tract, and severe systemic toxemia leading to myocarditis or polyneuropathy

Pathophysiologically, the goal is to prevent bacterial colonization, eliminate mucosal carriage, and halt the production of the diphtheria exotoxin, an agent responsible for localized tissue necrosis, pseudomembrane formation across the respiratory tract, and severe systemic toxemia leading to myocarditis or polyneuropathy

Pathophysiologically, the goal is to prevent bacterial colonization, eliminate mucosal carriage, and halt the production of the diphtheria exotoxin, an agent responsible for localized tissue necrosis, pseudomembrane formation across the respiratory tract, and severe systemic toxemia leading to myocarditis or polyneuropathy